Search Results 841-850 of 3825 for Herbicides
Subjects who are experiencing recurrent CDI will undergo screening procedures. Subjects who meet eligibility criteria will be eligible to be enrolled in the ...
Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.
The purpose of this study is to determine the efficacy of frexalimab in delaying the disability progression and the safety up to approximately 51 months ...
Learn about symptoms, risk factors, diagnosis and treatment, including transplant, for this rare cancer that affects the bile ducts of older adults.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.